Omeclamox-pak
NDC Package 65224-707-11
Package Information
Omeclamox-pak is a medication used to treat stomach/intestinal ulcers caused by the bacteria H. Marketed by Pernix Therapeutics, Llc, this product is identified by NDC 65224-707 and is authorized under FDA application NDA050824.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65224 - Pernix Therapeutics, Llc
- 65224-707 - Omeclamox-pak
- 65224-707-11 - 10 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK
- 65224-707 - Omeclamox-pak
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65224-707-11 identifies a specific commercial package of 10 blister pack in 1 carton / 1 kit in 1 blister pack of Omeclamox-pak, labeled by Pernix Therapeutics, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pernix Therapeutics, Llc on April 27, 2012. The current certification is valid through July 31, 2016.
What are the primary indications for this medication?
This product is used to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning. Treating ulcers reduces the risk of serious damage to the lining of the stomach/intestines (such as bleeding, tearing, blockage). Omeprazole is known as a proton pump inhibitor (PPI). It works by blocking acid production in the stomach. Decreasing excess stomach acid can help ulcers heal. Amoxicillin and clarithromycin are antibiotics used to treat a wide variety of bacterial infections (including H. pylori). Treating the infection helps reduce the risk of ulcers returning. Amoxicillin is a penicillin-type antibiotic and clarithromycin is a macrolide-type antibiotic. They work by stopping the growth of bacteria. The antibiotics in this product treat only bacterial infections. Antibiotics do not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Pernix Therapeutics, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65224070711. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.